Hi-Tech Pharmacal Co Inc $43.49

down 0.00


16/4/2014 08:10 PM  |  NASDAQ : HITK  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get HITK Trend Analysis - it has outperformed the S&P 500 by 10%

Partner Headlines

  1. Akorn Guidance Worries Street As Strategy Hits Delays

    IBD
  2. Akorn Q4 Meets But Guidance Disappoints, Stock Down

    IBD
  3. Specialty Pharma Gets Bigger

    IBD
  4. Actavis, Valeant, Jazz: New Roles For Specialty Pharma

    IBD
  5. Hi-Tech Pharmacal Receives FDA Final Approval for Bromfenac Ophthalmic ...

    Benzinga
  6. US Stock Futures Up; Jobless Claims Data In Focus

    Benzinga
  7. Hi-Tech Pharmacal Announces $25M Settlement Regarding Texas Pricing Investigation ...

    Benzinga
  8. Top 4 Stocks In The Drugs-Generic Industry With The Highest Operating Margin

    Benzinga
  9. Top 4 Stocks In The Drugs-Generic Industry With The Highest ROA

    Benzinga
  10. Top 4 Stocks In The Drugs-Generic Industry With The Highest Cash

    Benzinga
  11. Drugmaker Akorn Becoming Mighty Oak In Hi-Tech Merger

    IBD
  12. Chuck Royce Reductions - Lessons on Hold'em or Fold'em

    GuruFocus
  13. UPDATE: Hi-Tech Pharmacal Posts In-Line Q1 Earnings

    Benzinga
  14. Akorn doubles size in merger

    IBD
  15. Mid-Afternoon Market Update: DSW Rises as the NASDAQ Gets Crushed

    Benzinga
  16. Mid-Day Market Update: Hi-Tech Pharmacal Rises On Acquisition News; Sanderson ...

    Benzinga
  17. Akorn To Buy Hi-Tech Pharmacal; Both Stocks Jump

    IBD
  18. Mid-Morning Market Update: Markets Go Red; Tiffany Q2 Net Profit Surges ...

    Benzinga
  19. Morning Market Movers

    Benzinga
  20. Akorn to Acquire Hi-Tech Pharmacal for $640M in Cash, $43.50/Share

    Benzinga
  21. Top 4 Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

    Benzinga
  22. Hi-Tech Pharmacal Co., Inc. (HITK) VP and CFO William J Peters sells 4,639 ...

    GuruFocus
  23. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

    Benzinga
  24. The Royce Funds Makes Moves on Some Tech Stocks

    GuruFocus
  25. HiTech Pharmacal Co. Inc. Reports Operating Results (10-Q)

    GuruFocus
  26. Earnings Scheduled For December 6, 2012

    Benzinga
  27. Hi-Tech Pharmacal Announces $1.50/Share Special Dividend

    Benzinga
  28. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

    Benzinga
  29. HiTech Pharmacal Co. Inc. (HITK) Vice Chairman, Business Dev't Reuben Seltzer ...

    GuruFocus
  30. Hi-Tech Pharmacal Co. Reports Operating Results (10-Q)

    GuruFocus
  31. Hi-Tech Pharm misses badly

    IBD
  32. Hi-Tech Pharmacal Stock Plunges On Big Q1 Shortfall

    IBD
  33. Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest ROA

    Benzinga
  34. HiTech Pharmacal Co. Inc. (HITK) VP and CFO William J Peters sells 12,5 ...

    GuruFocus
  35. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Revenue

    Benzinga
  36. HiTech Pharmacal Co. Inc. Reports Operating Results (10-K)

    GuruFocus
  37. Earnings Scheduled For July 10

    Benzinga
  38. A Peek Into The Market Before The Trading Starts

    Benzinga
  39. Hi-Tech Phar Q3 misses views

    IBD
  40. There's No Magic Bullet

    GuruFocus
  41. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Operating ...

    Benzinga
  42. Value Idea Contest, A Year Later

    GuruFocus
  43. How to Trade Biotechs Based on the JP Morgan Health Care Conference

    Benzinga
  44. Stocks Up In Faster Trade; Caterpillar, Celgene Leap

    IBD
  45. End-of-Day Market Summary for January 10, 2012

    Benzinga
  46. How To Invest: Why Retailer Rue 21's Breakout Failed

    IBD
  47. How To Invest: Why Retailer Rue 21's Breakout Failed

    IBD
  48. Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin

    Benzinga
  49. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

    Benzinga
  50. HiTech Pharmacal Co. Inc. Reports Operating Results (10-Q)

    GuruFocus
Trading Center